FDCDDQ
XFOR icon

Federation des caisses Desjardins du Quebec’s X4 Pharmaceuticals XFOR Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-67
Closed -$1.34K – 2638
2024
Q3 		$1.34K Sell
67
-66
-50% -$1.38K ﹤0.01% 2288
2024
Q2 		$2.32K Hold
133
– – ﹤0.01% 2090
2024
Q1 		$5.56K Hold
133
– – ﹤0.01% 1942
2023
Q4 		$3.36K Hold
133
– – ﹤0.01% 1996
2023
Q3 		$4.36K Hold
133
– – ﹤0.01% 1944
2023
Q2 		$7.76K Hold
133
– – ﹤0.01% 1824
2023
Q1 		$3.48K Hold
133
– – ﹤0.01% 1993
2022
Q4 		$3.97K Hold
133
– – ﹤0.01% 2080
2022
Q3 		$6.84K Hold
133
– – ﹤0.01% 2003
2022
Q2 		$3.86K Hold
133
– – ﹤0.01% 2188
2022
Q1 		$7K Buy
+133
New +$7.63K ﹤0.01% 2119

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's XFOR Position: Q4 2024 in Review

Federation des caisses Desjardins du Quebec sold out of X4 Pharmaceuticals (XFOR) in Q4 2024, closing a stake of 67 shares — an estimated $1.34K sold.

Federation des caisses Desjardins du Quebec first reported a position in XFOR in Q1 2022 and held it in 11 quarters. The position peaked at $7.76K in Q2 2023. 89 funds tracked by Wall St. Rank hold XFOR as of Q4 2024.

  • Federation des caisses Desjardins du Quebec reported no remaining X4 Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 67 X4 Pharmaceuticals shares in Q4 2024, an estimated $1.34K.
  • Federation des caisses Desjardins du Quebec first reported a position in X4 Pharmaceuticals in Q1 2022 and held it in 11 quarters.
  • Federation des caisses Desjardins du Quebec's X4 Pharmaceuticals position peaked at $7.76K in Q2 2023.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q4 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2024, filed 14 Feb 2025.